Medical Action Industries Epidural/Pain TQC Kits Recall Over Compromised Sterility
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Medical Action Industries, Inc. is recalling 1,960 Epidural/Pain TQC kits because they contain sodium chloride ampules subject to another recall with potentially compromised sterility.
Reading this FDA recall beyond the headline
This notice was issued by FDA on September 22, 2026 and geographically references United States. The FDA classifies this as a Class I recall, with the stated reason "Kits containing Sodium Chloride ampules subject to another recall are recalled due to potentially compromised sterility.", distributed us distribution to states of: ia, va, mo, ks, fl, oh and ls.. FDA recall classes run from I (reasonable probability of serious harm) to III (unlikely to cause harm), so the class number is the fastest way to gauge severity here. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
It is tempting to skim, check personal relevance, and move on. The better habit is confirming scope, source, and timestamp first, then reading this alongside related notices instead of drawing a conclusion from one record alone.
Before acting, the primary agency source is available to check alongside this summary. Its related labels are recall, product-safety, fda, Medical Devices.
What Happened
Medical Action Industries, Inc. is recalling certain epidural/pain kits because they contain Sodium Chloride Injection ampules subject to another recall, resulting in potentially compromised sterility.
Which Products Are Affected
The recall covers Kit: Epidural/Pain TQC 20/Cs, REF: 82465 Containing Sodium Chloride Injection, 0.9%, USP 10ml ampules. A total of 1,960 units are affected. UDI-DI: 10809160367414. Affected lots (with expiration dates): 322200(4/1/2026), 324586(4/1/2026), 327335(4/1/2026), 329618(9/1/2026), 347199(11/1/2026), 337283(11/1/2026), 350354(11/30/2026), 375449(5/31/2027). Distribution was limited to the states of IA, VA, MO, KS, FL, OH and LS. Recall number Z-3106-2026. Classification: Class I. Recall initiation date: July 23, 2026.
What You Should Do
Consumers and healthcare facilities should follow instructions provided by the recalling firm regarding the affected kits.
Why This Matters
The Class I recall indicates a reasonable probability that use of the affected devices could cause serious adverse health consequences due to potential sterility issues.
Source
FDA Enforcement Report, recall number Z-3106-2026, Medical Action Industries, Inc.
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Getinge PVC Thoracic Catheters Recall Over Bacterial Endotoxin Testing (Aug 7, 2026)
FDA · September 22, 2026
C.R. Bard Foley Catheter Trays Recall Over Pericare Wipes Contamination (Jun 25, 2026)
FDA · September 22, 2026
Given Imaging Bravo CF Capsule Delivery Device Recall Over Detachment Risk
FDA · September 22, 2026
Elsewhere in the country: similar length or severity timing 8
Two Areazine-derived peer sets for this FDA recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (1,215 characters here).
Similar severity timing
Same severity (high) notices issued closest in time to September 22, 2026.
Frequently Asked Questions
What people usually ask about a notice like this one.